meRfi®-GM
Ezetimibe
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Ezetimibe acts by decreasing cholesterol absorption in the small intestine and lowers plasma cholesterol levels
Clostridium XVIII and Lachnospiracea incertae sedis were negatively correlated with total cholesterol (TC) and LDL-C after ezetimibe intervention
In contrast, TG, total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) were significantly decreased by ezetimibe
Jin et al. 2021b Front. Pharmacol. 12: 73254…
References (Sources)
- Distinctive Gut Microbiota in Patients with Overweight and Obesity with Dyslipidemia and its Responses to Long-term Orlistat and Ezetimibe Intervention: A Randomized Controlled Open-label Trial
- The Effect of Orlistat and Ezetimibe, Alone or in Combination, on Serum LDL and Small Dense LDL Cholesterol Levels in Overweight and Obese Patients with Hypercholesterolaemia